Distrobird — Free Sales Engagement Platform
Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.
Create a sequence — it's free
Irlab Therapeutics Ab
irlab therapeutics ab (publ), a research and development company, develops drugs for the treatment of parkinson's disease. the company develops mesdopetam, a dopamine d3 receptor antagonist that has completed phase iia clinical trial for the treatment of dyskinesia; irl752 that has completed phase iia clinical trial to treat postural dysfunction; and irl942 and 1009, a research program for the treatment of neurodegenerative disorders and ageing. it also develops p001, a research project for neurodegenerative disorders and aging; p003, a research project aiming at developing drugs that can substitute levodopa as the treatment of parkinson's disease; and irl448/irl555, a followâup to parkinson's disease program. the company is based in gothenburg, sweden.
Frequently asked questions about Irlab Therapeutics Ab
Let us help answer the most common questions you might have.
Where is Irlab Therapeutics Ab located?
Irlab Therapeutics Ab's headquarters is located at Goteborg, Vastra Gotaland, Sweden
What is Irlab Therapeutics Ab's official website?
Irlab Therapeutics Ab's official website is irlab.se
What is Irlab Therapeutics Ab's SIC code?
What is Irlab Therapeutics Ab's NAICS code?
How many employees does Irlab Therapeutics Ab have?
Irlab Therapeutics Ab has 27 employees
What industry does Irlab Therapeutics Ab belong to?
Irlab Therapeutics Ab is in the industry of: Biotechnology
What are Irlab Therapeutics Ab's social media links?
Irlab Therapeutics Ab Linkedin page
Distrobird — Free Sales Engagement Platform
Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.
Create a sequence — it's free